OTONOMY INC(NASDAQ:OTIC) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to OTIC. OTIC was compared to 198 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of OTIC have multiple concerns. OTIC is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

OTIC had negative earnings in the past year.

OTIC had a negative operating cash flow in the past year.

1.2 Ratios

OTIC has negative profitability rations, so we won't be analyzing them here.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

OTIC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OTIC does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, OTIC has more shares outstanding

Compared to 1 year ago, OTIC has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -16.93, we must say that OTIC is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -16.93, OTIC is doing worse than 90.99% of the companies in the same industry.

A Debt/Equity ratio of 0.01 indicates that OTIC is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.01, OTIC is in line with its industry, outperforming 49.10% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Altman-Z	-16.93

ROIC/WACCN/A

WACC10.41%

2.3 Liquidity

OTIC has a Current Ratio of 1.74. This is a normal value and indicates that OTIC is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of OTIC (1.74) is worse than 75.23% of its industry peers.

A Quick Ratio of 1.74 indicates that OTIC should not have too much problems paying its short term obligations.

With a Quick ratio value of 1.74, OTIC is not doing good in the industry: 69.82% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	1.74
Quick Ratio	1.74

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.94% over the past year.

The Revenue for OTIC has decreased by -100.00% in the past year. This is quite bad

The Revenue for OTIC have been decreasing by -28.73% on average. This is quite bad

EPS 1Y (TTM)4.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%5.26%

Revenue 1Y (TTM)-100%

Revenue growth 3Y-44.97%

Revenue growth 5Y-28.73%

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 2.08% on average over the next years.

Based on estimates for the next years, OTIC will show a very negative growth in Revenue. The Revenue will decrease by -14.87% on average per year.

EPS Next Y3.04%

EPS Next 2Y10.42%

EPS Next 3Y-0.66%

EPS Next 5Y2.08%

Revenue Next Year-100%

Revenue Next 2Y-41.42%

Revenue Next 3Y-25.99%

Revenue Next 5Y-14.87%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OTIC. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OTIC. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y10.42%

EPS Next 3Y-0.66%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for OTIC!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

OTONOMY INC

NASDAQ:OTIC (12/22/2022, 8:00:02 PM)

After market: 0.083 +0.01 (+7.79%)

0.077

-0.01 (-11.19%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)11-10 2022-11-10/amc

Earnings (Next)02-27 2023-02-27

Inst Owners0%

Inst Owner Change0%

Ins Owners10.54%

Ins Owner Change0%

Market Cap4.40M

Analysts77.78

Price Target9.18 (11822.08%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)6.99%

Min EPS beat(2)6.86%

Max EPS beat(2)7.12%

EPS beat(4)3

Avg EPS beat(4)2.53%

Min EPS beat(4)-7.44%

Max EPS beat(4)7.12%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)N/A

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)-4.52%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	0.21
P/tB	0.21
EV/EBITDA	N/A

EPS(TTM)-0.77

EYN/A

EPS(NY)-0.63

Fwd EYN/A

FCF(TTM)-0.82

FCFYN/A

OCF(TTM)-0.82

OCFYN/A

SpS0

BVpS0.37

TBVpS0.37

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score2

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	43.04%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.74
Quick Ratio	1.74
Altman-Z	-16.93

F-Score2

WACC10.41%

ROIC/WACCN/A

Cap/Depr(3y)35.87%

Cap/Depr(5y)49.46%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)4.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%5.26%

EPS Next Y3.04%

EPS Next 2Y10.42%

EPS Next 3Y-0.66%

EPS Next 5Y2.08%

Revenue 1Y (TTM)-100%

Revenue growth 3Y-44.97%

Revenue growth 5Y-28.73%

Sales Q2Q%N/A

Revenue Next Year-100%

Revenue Next 2Y-41.42%

Revenue Next 3Y-25.99%

Revenue Next 5Y-14.87%

EBIT growth 1Y-8.95%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-22.84%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-23.44%

OCF growth 3YN/A

OCF growth 5YN/A

OTONOMY INC (OTIC) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens